Real-world crude incidence of hypoglycemia in adults with diabetes: Results of the InHypo-DM Study, Canada
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Objective: Very few real-world studies have been conducted to assess the incidence of diabetes-related hypoglycemia. Moreover, there is a paucity of studies that have investigated hypoglycemia among people taking secretagogues as a monotherapy or in combination with insulin. Accordingly, our research team developed and validated the InHypo-DM Person with Diabetes Mellitus Questionnaire (InHypo-DMPQ) with the aim of capturing the real-world incidence of self-reported, symptomatic hypoglycemia. The questionnaire was administered online to a national sample of Canadians (≥18 years old) with type 1 diabetes mellitus (T1DM) or type 2 diabetes mellitus (T2DM) treated with insulin and/or insulin secretagogues. Research design and methods: Self-report data obtained from the InHypo-DMPQ were descriptively analyzed to ascertain the crude incidence proportions and annualized incidence densities (rates) of 30-day retrospective non-severe and 1-year retrospective severe hypoglycemia, including daytime and nocturnal events. Results: A total of 552 people (T2DM: 83%; T1DM: 17%) completed the questionnaire. Over half (65.2%) of the total respondents reported experiencing at least one event (non-severe or severe) at an annualized crude incidence density of 35.1 events per person-year. The incidence proportion and rate of non-severe events were higher among people with T1DM versus T2DM (77% and 55.7 events per person-year vs 54% and 28.0 events per person-year). Severe hypoglycemia was reported by 41.8% of all respondents, at an average rate of 2.5 events per person-year. Conclusions: The results of the InHypo-DMPQ, the largest real-world investigation of hypoglycemia epidemiology in Canada, suggest that the incidence of hypoglycemia among adults with diabetes taking insulin and/or insulin secretagogues is higher than previously thought.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hypoglycemia is very common; up to 65% of individuals with either type 1 or type 2 diabetes (treated with insulin or insulin secretagogues) self-report at least 1 episode of hypoglycemia in a given year, with a higher incidence in people with type 1 diabetes [11].”
From Hypoglycemia in Adults (2023) · cites this paper as [11]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Costello, A. B., & Osborne, J. (2005) · University of Massachusetts Amherst · doi:10.7275/jyj1-4868 · Cited by 10,297 · cited 1×
“sample size The sample size of 552 respondents was based on objective 1 of the InHypo-DMPQ (refer to the Study design section).(38)”
MethodU.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, & U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health (2006) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-4-79 · Cited by 2,856
Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R. (2013) · Diabetes Care · doi:10.2337/dc12-2480 · Cited by 1,389 · cited 1×
“Notwithstanding, the outcome measures, based on participant self-report, employed in the current study encompassed several pragmatic classifications of hypoglycemia considered important in the clinical management of diabetes: documented symptomatic hypoglycemia, probable symptomatic hypoglycemia, as well as pseudo-hyp…”
BackgroundBooth, G., & Cheng, A. Y. Y. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.010 · Cited by 1,220
Peyrot, M., Rubin, R. R., Lauritzen, T., Snoek, F. J., Matthews, D. R., & Skovlund, S. E. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01644.x · Cited by 931
Risk of hypoglycaemia in types 1 and 2 diabetes: Effects of treatment modalities and their duration
UK Hypoglycaemia Study Group (2007) · Diabetologia · doi:10.1007/s00125-007-0599-y · Cited by 825
Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes.
Cryer, P. (2002) · Diabetologia · doi:10.1007/s00125-002-0822-9 · Cited by 794
Cheng, A. Y. Y. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.009 · Cited by 728
The barrier of hypoglycemia in diabetes
Cryer, P. E. (2008) · Diabetes · doi:10.2337/db08-1084 · Cited by 725
Klonoff, D. C. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1231 · Cited by 724
Hypoglycaemia in Type 2 diabetes
Amiel, S. A., Dixon, T., Mann, R., & Jameson, K. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02341.x · Cited by 472 · cited 1×
“11 To avoid hypoglycemia, many people with T1DM or T2DM will intentionally maintain their plasma glucose levels above recommended values, ultimately increasing their risk of long-term microvascular and macrovascular complications.(12) This risk is further exacerbated by clinical inertia among healthcare providers (HCP…”
BackgroundBodmer, M., Meier, C., Krähenbühl, S., Jick, S. S., & Meier, C. R. (2008) · Diabetes Care · doi:10.2337/dc08-1171 · Cited by 426
A Review of Diabetes Treatment Adherence and the Association with Clinical and Economic Outcomes
Asche, C., LaFleur, J., & Conner, C. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.01.019 · Cited by 420
Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway
Skrivarhaug, T., Bangstad, H.-J., Stene, L. C., Sandvik, L., Hanssen, K. F., & Joner, G. (2006) · Diabetologia · doi:10.1007/s00125-005-0082-6 · Cited by 390
Symptomatic Hypoglycaemia in 411 Type 1 Diabetic Patients
Pramming, S., Thorsteinsson, B., Bendtson, I., & Binder, C. (1991) · Diabetic Medicine · doi:10.1111/j.1464-5491.1991.tb01575.x · Cited by 337
Khunti, K., Alsifri, S., Aronson, R., Cigrovski Berković, M., Enters‐Weijnen, C., Forsén, T., Galstyan, G., Geelhoed‐Duijvestijn, P., Goldfracht, M., Gydesen, H., et al. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12689 · Cited by 276
Assessment of the Impact of Fear of Hypoglycemic Episodes on Glycemic and Hypoglycemia Management
Leiter, L. A., Yale, J., Chiasson, J., Harris, S. B., & Kleinstiver, P. W. (2005) · Cited by 250
Self-citationRecall of severe hypoglycaemia and self‐estimated state of awareness in type 1 diabetes
Pedersen‐Bjergaard, U., Pramming, S., & Thorsteinsson, B. (2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.377 · Cited by 240 · cited 1×
“50 One study, which investigated a cohort of insulin-treated patients with T1DM, found that nearly 90% of participants correctly recalled whether they had a severe hypoglycemia event in the previous year.(51) Fourth, some characteristics that may influence risk of hypoglycemia were not explicitly captured in the curre…”
BackgroundEdridge, C. L., Dunkley, A. J., Bodicoat, D. H., Rose, T. C., Gray, L. J., Davies, M. J., & Khunti, K. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126427 · Cited by 225
Sonne, D. P., & Hemmingsen, B. (2017) · Diabetes Care · doi:10.2337/dc17-0299 · Cited by 189
Feltbower, R. G., Bodansky, H. J., Patterson, C. C., Parslow, R. C., Stephenson, C. R., Reynolds, C., & McKinney, P. A. (2008) · Diabetes Care · doi:10.2337/dc07-2029 · Cited by 183
Piaggesi, A., Schipani, E., Campi, F., Romanelli, M., Baccetti, F., Arvia, C., & Navalesi, R. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199805)15:5<360::aid-dia568>3.0.co;2-w · Cited by 182
Sarkar, U., Karter, A. J., Liu, J. Y., Moffet, H. H., Adler, N. E., & Schillinger, D. (2010) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1389-7 · Cited by 173
Self‐reported non‐severe hypoglycaemic events in Europe
Östenson, C. G., Geelhoed‐Duijvestijn, P., Lahtela, J., Weitgasser, R., Markert Jensen, M., & Pedersen‐Bjergaard, U. (2014) · Diabetic Medicine · doi:10.1111/dme.12261 · Cited by 168
The economic and quality of life impact of hypoglycemia
Lundkvist, J., Berne, C., Bolinder, B., & Jönsson, L. (2005) · The European Journal of Health Economics · doi:10.1007/s10198-005-0276-3 · Cited by 165 · cited 1×
“It is often unpredictable and recurrent,(5) resulting in potentially severe physical(6) and psychosocial(7) morbidity, as well as associated economic burden.(8) 9 Hypoglycemia can also be life-threatening, accounting for 6%–10% of all diabetes-related mortalities, according to recent data.”
BackgroundElliott, L., Fidler, C., Ditchfield, A., & Stissing, T. (2016) · Diabetes Therapy · doi:10.1007/s13300-016-0157-z · Cited by 135
Perceived symptoms of hypoglycaemia in elderly Type 2 diabetic patients treated with insulin
Jaap, A. J., Jones, G. C., McCrimmon, R. J., Deary, I. J., & Frier, B. M. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199805)15:5<398::aid-dia595>3.0.co;2-b · Cited by 133 · cited 1×
“Third, self-reported event data may have been subject to recall bias, especially among older individuals who are more likely to suffer from impaired hypoglycemia awareness.(48) To reduce this potential risk, measures were taken to ensure that all selected recall intervals optimized respondents’ abilities to remember e…”
BackgroundHerman, W. H., Petersen, M., & Kalyani, R. R. (2017) · Diabetes Care · doi:10.2337/dci17-0007 · Cited by 124
Foos, V., Varol, N., Curtis, B. H., Boye, K. S., Grant, D., Palmer, J. L., & McEwan, P. (2015) · Journal of Medical Economics · doi:10.3111/13696998.2015.1006730 · Cited by 120 · cited 1×
“A recent study that summarized the economic burden of hypoglycemia across 14 studies in the USA found that severe hypoglycemia requiring non-medical assistance resulted in higher indirect costs among patients with T2DM than in patients with T1DM ($579 vs $242).(40) The substantial absolute burden of hypoglycemia in T2…”
BackgroundSchopman, J. E., Simon, A. C. R., Hoefnagel, S. J. M., Hoekstra, J. B. L., Scholten, R. J. P. M., & Holleman, F. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2470 · Cited by 120
Smith, C. B., Choudhary, P., Pernet, A., Hopkins, D., & Amiel, S. A. (2009) · Diabetes Care · doi:10.2337/dc08-2259 · Cited by 106
Hypoglycemia: Pathophysiology, Diagnosis, and Treatment
Cryer, P. E. (1997) · Medical Entomology and Zoology · Cited by 86
Lüddeke, H. ‐., Sreenan, S., Aczel, S., Maxeiner, S., Yenigun, M., Kozlovski, P., Gydesen, H., Dornhorst, A., & PREDICTIVE Study Group (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00677.x · Cited by 86
Incidence and Costs of Severe Hypoglycemia
Holstein, A., Plaschke, A., & Egberts, E.-H. (2002) · Diabetes Care · doi:10.2337/diacare.25.11.2109 · Cited by 72
Monami, M., Dicembrini, I., Kundisova, L., Zannoni, S., Nreu, B., & Mannucci, E. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12287 · Cited by 68
Hypoglycemia: Pathophysiology, Diagnosis, and Treatment
Cryer, P. E. (1997) · doi:10.1093/oso/9780195113259.001.0001 · Cited by 68
Geelhoed-Duijvestijn, P. H., Pedersen-Bjergaard, U., Weitgasser, R., Lahtela, J., Jensen, M. M., & Östenson, C.-G. (2013) · Journal of Medical Economics · doi:10.3111/13696998.2013.852098 · Cited by 64
Hypoglycemia in diabetes: common, often unrecognized.
Gabriely, I., & Shamoon, H. (2004) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.71.4.335 · Cited by 58 · cited 1×
“Furthermore, it is important to note that estimates of self-reported severe hypoglycemia tend to be rather reliable, given the saliency and relative infrequency of events.(49) 50 One study, which investigated a cohort of insulin-treated patients with T1DM, found that nearly 90% of participants correctly recalled wheth…”
BackgroundBrod, M., Wolden, M., Christensen, T., & Bushnell, D. M. (2013) · Value in Health · doi:10.1016/j.jval.2013.09.002 · Cited by 56
Leiter, L. A., Boras, D., & Woo, V. C. (2014) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.08.270 · Cited by 48
Continuous Glucose Monitoring: Impact on Hypoglycemia
van Beers, C. A. J., & DeVries, J. H. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816653411 · Cited by 41
Aronson, R., Goldenberg, R., Boras, D., Skovgaard, R., & Bajaj, H. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.01.007 · Cited by 34
Early Insulin: An Important Therapeutic Strategy
DAILEY, G. E. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.220 · Cited by 32
Munro, N., & Barnett, A. H. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12388 · Cited by 24
Access to emergency room for hypoglycaemia in people with diabetes
Salutini, E., Bianchi, C., Santini, M., Dardano, A., Daniele, G., Penno, G., Miccoli, R., & Prato, S. D. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2667 · Cited by 18 · cited 1×
“Importantly, none of these Canadian-based studies specifically investigated the distribution of hypoglycemia among people taking secretagogues (alone or in combination with insulin), despite the known potential of these medications to induce hypoglycemia; in fact, people taking sulfonylureas have been shown to experie…”
BackgroundBrož, J., Brabec, M., Žďarská, D. J., Fedáková, Z., Pospíšilová, L., You, J., Doničová, V., Hlaďo, P., Rahelić, D., Kvapil, M., et al. (2015) · Patient Preference and Adherence · doi:10.2147/ppa.s87393 · Cited by 16
Statin Adverse Events in Primary Prevention: Between Randomized Trials and Observational Studies
Mansi, I. A., & Palmer, B. F. (2015) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000527 · Cited by 15 · cited 2×
“…28 Conversely, some observational study designs may overestimate the incidence of adverse events; common caveats, according to a study by Mansi (2015), include sampling, response, and surveillance bias, as well as confounding by indication.29 Contemporary real-world population-based…”
BackgroundReichert, S. M., Harris, S. B., Mequanint, S., Ryan, B. L., Webster-Bogaert, S., Ratzki‐Leewing, A. A., & Brown, J. B. (2016) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.08.164 · Cited by 6
Self-citationHarris, S. B., Reichert, S. M., Ryan, B. L., Mequanint, S., Webster-Bogaert, S., Ratzki‐Leewing, A. A., & Brown, J. B. (2016) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.08.033 · Cited by 5
Self-citationHypoglycemia Rates in Type 2 Diabetes Mellitus Differ by Medication Type (InHypo-DM Canada)
Ratzki‐Leewing, A. A., Harris, S. B., Ryan, B. L., Reichert, S. M., Mequanint, S., Webster-Bogaert, S., & Brown, J. B. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.08.191 · Cited by 1
Self-citation
Research works printed but not linked: 2
- 33. Reichert S, Harris S, Ryan B, et al. A Population-Based Study on Incidence and Associated Risk Factors for Hypoglycaemia in Canada: The InHYPO-DM Study. Can J Diabetes 2016;59(Suppl1):S394-5.
- 36. Ratzki-Leewing A, Harris S, Ryan B, et al. A Survey of Canadians with Diabetes: Insight into Hypoglycemia Management (The InHYPO-DM Study). Can J Diabetes 2016;65:A105.
Cited by
Silbert, R., Salcido-Montenegro, A., Rodriguez-Gutierrez, R., Katabi, A., & McCoy, R. G. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1018-0 · Cited by 229
“[53] Reliability of self-reported measures of hypoglycemia is contingent on confidence in patients’ hypoglycemia awareness, willingness to report events, and ability to differentiate true hypoglycemia from pseudo-hypoglycemia.”
Lacy, M. E., Gilsanz, P., Eng, C., Beeri, M. S., Karter, A. J., & Whitmer, R. A. (2020) · Diabetes Care · doi:10.2337/dc19-0906 · Cited by 131
Pease, A., Zomer, E., Liew, D., Earnest, A., Soldatos, G., Ademi, Z., & Zoungas, S. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0064 · Cited by 39
Karamanakos, G., Kokkinos, A. D., Dalamaga, Μ., & Liatis, S. (2022) · Current Obesity Reports · doi:10.1007/s13679-022-00477-x · Cited by 49
Brown, J. B., Reichert, S. M., Valliere, Y., Webster-Bogaert, S., Ratzki‐Leewing, A. A., Ryan, B. L., & Harris, S. B. (2019) · Diabetes Spectrum · doi:10.2337/ds18-0074 · Cited by 38
“The objectives of this mixed-methods study were: 1) to explore, using quantitative and qualitative methods, the psychosocial and situational factors that can facilitate or impede hypoglycemia self-management behaviors among people with diabetes, significant others of people with diabetes, and health care providers (HC…”
BackgroundMethodSelf-citation
Metadata
- Authors
- Ratzki-Leewing, A., Harris, S. B., Mequanint, S., Reichert, S. M., Belle Brown, J., Black, J. E., & Ryan, B. L.
- Affiliations
- Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada
- Western University (CA)
- Department of Family Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada
- Corresponding author
- Harris, Stewart B
- Venue
- BMJ Open Diabetes Research & Care
- Publisher
- BMJ
- Published
- 2018-04
- Volume
- 6
- Issue
- 1
- Pages
- e000503
- ISSN
- 2052-4897 (ISSN-L)
- PMC
- PMC5922478
- OpenAlex
- W2799495728
- Cited by
- 90
- References
- 49
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 10 · 2023: 17 · 2022: 19 · 2021: 16 · 2020: 12 · 2019: 5 · 2018: 2
- FWCI
- 6.96
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- BMJ Open Diabetes Research & Care (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Scholarship@Western (Western University) (submittedVersion)
- Funders
- Sanofi Canada
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
- Keywords
- hypoglycemia, diabetes mellitus, type 1 diabetes, type 2 diabetes, hypoglycemia incidence, severe hypoglycemia, insulin, insulin secretagogues, nocturnal hypoglycemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.